F1FB1_15 Medicinal Chemistry I

Faculty of Pharmacy
Spring 2021
Extent and Intensity
3/1/0. 3 credit(s). Type of Completion: z (credit).
Teacher(s)
prof. RNDr. Jozef Csöllei, CSc. (lecturer)
doc. PharmDr. Oldřich Farsa, Ph.D. (lecturer)
Mgr. Aleš Kroutil, Ph.D. (lecturer)
doc. PharmDr. Oldřich Farsa, Ph.D. (seminar tutor)
PharmDr. Tomáš Goněc, Ph.D. (seminar tutor)
Guaranteed by
doc. PharmDr. Oldřich Farsa, Ph.D.
Department of Chemical Drugs – Departments – Faculty of Pharmacy
Supplier department: Department of Chemical Drugs – Departments – Faculty of Pharmacy
Timetable
Thu 8:00–9:30 44-056, Thu 11:30–12:15 44-056
  • Timetable of Seminar Groups:
F1FB1_15/01: each odd Friday 7:30–9:00 44-037, T. Goněc
F1FB1_15/02: each odd Friday 9:15–10:45 44-037, T. Goněc
F1FB1_15/03: each even Friday 7:30–9:00 44-037, O. Farsa
F1FB1_15/04: each even Friday 9:15–10:45 44-037, T. Goněc
Course Enrolment Limitations
The course is also offered to the students of the fields other than those the course is directly associated with.
The capacity limit for the course is 160 student(s).
Current registration and enrolment status: enrolled: 26/160, only registered: 0/160, only registered with preference (fields directly associated with the programme): 0/160
fields of study / plans the course is directly associated with
Course objectives
Medicinal Chemistry (MC) is a discipline dealing mainly with relationships between chemical structure and therapeutic activity of medicines which are mostly organic but also inorganic molecules. That is why it observes the impact of physico-chemical properties, space arrangement and further structure features on the activity of a drug. It concerns in detail with mechanisms of drug intearactions with target structures such as receptors´ or enzyme active sites. As a scientific discipline, MC participates importantly in the drug design and development process. As a specific discipline of the pharmacetical study, MC is one of five stem subjects in which students do the state final exam. Here, MC can be divided into general and special parts. General MC presents general aspects of structure-activity relationships, both qulitative and quantitative, as well as common principles of derivation and proposal of structures of new medicines (analogy, homology, isomerism, isosterism...). Systematic MC deals then with the particular therapeutic groups of drugs respecting the system used in pharmacology. Here, it brings a comprehensive overwiev of fundamental structural types and tries to grasp main structure-activity relationships within each group. It also reports syntheses and methabolic pathways of some representatives of these groups. Simply said, MC builds some type of bridge between fundamental chemical disciplines, represented mainly by organic chemistry, and pharmacology.
Learning outcomes
After passing the subject, students will have to know, explain, present or draw as follows: -main principles of general Medicinal Chemistry
-therapeutic groups presented in seminars, ie. INN names and structures of main representatives, fundamental structure-activity relationships (SAR), brief mechanism of action
-the same for groups presented in seminars
Syllabus
  • Medicinal Chemistry is one of five profile disciplines of pharmaceutical education. It is also a part of final state examination. Medicinal Chemistry I. covers nomenclature of drugs, their syntheses, structure-activity relationships, biotransformation and some selected approaches of drug design. It deals with a drug, prepared using synthetic approaches with defined structure and properties, related with its therapeutical usage in treatment of pathological states and defined diseases.
    Syllabi of lectures
  • Medicinal Chemistry: Definition and history. Drug nomenclature.(Farsa)
    Drugs research and development. Drug patents. Approavals of drug preparations. Good laboratory, manufacturing and clinical practices (GLP, GMP, GCP). (Krouti)
    Structure midifications: homology, analogy, isomerism, isosterism etc. (Goněc)
    Physico-chemical descriptors and biological activity. Structure-activity relationships. Structure optimization. Quantitative structure-activity relationships (QSAR).(Farsa)
    Structural factors influencing drug action. (Farsa)
    Drugs biotransformation. Prodrugs.
    Weak analgesics and non-steroidal antiinflammatory drugs (NSAIDs). Anti-osteoporotic agents.(Farsa)
    General and local anesthetics. Myorelaxants. (Farsa)
    Strong analgesics - anodyns. Morphine and its derivatives. Encephalins, endorphins, opioid receptors antagonists. (Farsa)
    CNS agents: antidepressants, stimulants, cognitive enhancers, psychotomimetics - halucinogens.(Farsa)
    CNS agents: antipsychotics, antineurotics.(Farsa)
    Sedatives, hypnotics. Anticonvulsans, antiepileptics. Emetics, antivomitics, antikinetics. (Farsa)
    Adrenergic receptor agonists directly and indirectly acting. Appetite suppressants and other antiobesics. (Goněc)
    Adrenergic receptor antagonists. (Goněc)
Literature
    required literature
  • M. Wolff. Burger´s Medicinal Chemistry and Drug Discovery. New York, 1994. info
Teaching methods
On-line lectures via MS Teams;
seminars in the same way.
Assessment methods
The credit is given for a satisfactory point evaluation of the seminar's presentation and at least 60 % of the credit test points.
Language of instruction
Czech
Further Comments
Study Materials
The course can also be completed outside the examination period.
Listed among pre-requisites of other courses
The course is also listed under the following terms Spring 2020, Spring 2022, Spring 2023, Spring 2024, Spring 2025.
  • Enrolment Statistics (Spring 2021, recent)
  • Permalink: https://is.muni.cz/course/pharm/spring2021/F1FB1_15